The 2nd International Conference on Glycoprotein & Related Storage Diseases will create a venue for reviewing research progress and future objectives for these rare Lysosomal Storage Diseases. ISMRD's objectives are to present a venue for the leading research and clinical researchers in the LSD field to meet, present and discuss current and future opportunities for Glycoprotein Storage Diseases. It will also enable affected families to gather, meet and support one another and to interact with attending scientists and physicians. By doing so, we hope to focus attention on these diseases, the people they affect and the dedicated professionals who share our vision of a future devoid of hope.

In the three years since the world's first dedicated conference on these diseases in Rockville, Maryland USA, some significant developments for some of these diseases are underway. These include the ongoing research for an Enzyme Therapy for Alpha-Mannosidosis by the Hue-Man Project in Europe, and the initiation of the first Natural History Study of patients with Mucolipidosis II and III. Additional milestones are possible for other Glycoprotein Storage Diseases and these will be presented or proposed during this two day scientific and family conference.

 

 

 

 

Funding for this conference was made possible (in part) by NS060583 from National Institute of Neurological Disorders and Stroke (NINDS) and the Office of Rare Diseases (ORD). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.